(Q49028447)

English

Children <1 year show an inferior outcome when treated according to the traditional LGG treatment strategy: a report from the German multicenter trial HIT-LGG 1996 for children with low grade glioma (LGG).

scientific article published on 4 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

Children <1 year show an inferior outcome when treated according to the traditional LGG treatment strategy: a report from the German multicenter trial HIT-LGG 1996 for children with low grade glioma (LGG). (English)

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

multicenter clinical trial

1 reference

based on heuristic

inferred from title

low grade glioma

1 reference

based on heuristic

inferred from title

Stephan von Hornstein

8

object named as

Stephan von Hornstein

1 reference

Europe PubMed Central

17 February 2018

Monika Warmuth-Metz

5

object named as

Monika Warmuth-Metz

1 reference

Europe PubMed Central

17 February 2018

author name string

Cora Mirow

1

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

Torsten Pietsch

2

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

Susanne Berkefeld

3

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

Robert Kwiecien

4

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

Fabian Falkenstein

6

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

Barbara Diehl

7

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

Astrid K Gnekow

9

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

publication date

4 September 2013

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

Pediatric Blood Cancer

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

61

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

457-463

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

3

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Natural history and outcome of optic pathway gliomas in children

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Survival and functional outcome of children with hypothalamic/chiasmatic tumors.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

High response rate to cisplatin/etoposide regimen in childhood low-grade glioma

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

The new WHO classification of brain tumours

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Long-term results of brachytherapy with temporary iodine-125 seeds in children with low-grade gliomas

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Benign cerebellar astrocytoma in childhood: experience at the Hospital for Sick Children 1980-1992.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Diencephalic syndrome revisited

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Treatment of diencephalic syndrome with chemotherapy: growth, tumor response, and long term control.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamic-optic chiasm region.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Successful treatment with a low-dose cisplatin--etoposide regimen for patients with diencephalic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Relapses of optic pathway tumors after first-line chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Tumor stabilization under treatment with imatinib in progressive hypothalamic-chiasmatic glioma

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

MAPK pathway activation in pilocytic astrocytoma

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24729

21 January 2018

Identifiers

10.1002/PBC.24729

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/24039013

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49028447&oldid=1536758832"